AbbVie Inc. | Mega-cap | Healthcare
$182.38
-2.36%
| AbbVie Stock Comparison:
AbbVie vs Eli Lilly andAbbVie vs Johnson & JohnsonAbbVie vs Merck & CoAbbVie vs AmgenAbbVie vs Gilead SciencesAbbVie vs S&P 500 | Market
Overview Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

Financial Overview

Latest Annual: 2024

Income Metrics

Revenue 56.3B
Gross Profit 39.4B 69.99%
Operating Income 11.9B 21.11%
Net Income 4.3B 7.61%
EPS (Diluted) $2.39

Balance Sheet Metrics

Total Assets 135.2B
Total Liabilities 131.8B
Shareholders Equity 3.4B
Debt to Equity 39.18

Cash Flow Metrics

Operating Cash Flow 13.5B
Free Cash Flow 17.8B

Revenue & Profitability Trend

AbbVie Income Statement From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Revenue 56.3B 54.3B 58.1B 56.2B 45.8B
Cost of Goods Sold 16.9B 20.4B 17.4B 17.4B 15.4B
Gross Profit 39.4B 33.9B 40.6B 38.8B 30.4B
Operating Expenses 27.5B 21.1B 22.5B 20.8B 19.1B
Operating Income 11.9B 12.8B 18.1B 17.9B 11.4B
Pre-tax Income 3.7B 6.2B 13.5B 13.0B 3.4B
Income Tax -570.0M 1.4B 1.6B 1.4B -1.2B
Net Income 4.3B 4.9B 11.8B 11.5B 4.6B
EPS (Diluted) $2.39 $2.72 $6.63 $6.45 $2.62

Income Statement Trend

AbbVie Balance Sheet From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Assets
Current Assets 25.6B 33.0B 28.5B 27.9B 24.2B
Non-Current Assets 109.6B 101.7B 110.3B 118.6B 126.4B
Total Assets 135.2B 134.7B 138.8B 146.5B 150.6B
Liabilities
Current Liabilities 38.7B 37.8B 29.5B 35.2B 28.7B
Non-Current Liabilities 93.0B 86.5B 92.0B 95.9B 108.8B
Total Liabilities 131.8B 124.3B 121.5B 131.1B 137.5B
Equity
Total Shareholders Equity 3.4B 10.4B 17.3B 15.4B 13.1B

Balance Sheet Composition

AbbVie Cash Flow Statement From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Operating Activities
Net Income 4.3B 4.9B 11.8B 11.5B 4.6B
Operating Cash Flow 13.5B 19.2B 22.4B 22.8B 17.5B
Investing Activities
Capital Expenditures -974.0M -777.0M -695.0M -787.0M -798.0M
Investing Cash Flow -20.8B -2.0B -623.0M -2.3B -37.6B
Financing Activities
Dividends Paid -11.0B -10.5B -10.0B -9.3B -7.7B
Financing Cash Flow -10.4B -17.4B -25.1B -19.3B -11.7B
Free Cash Flow 17.8B 22.1B 24.2B 22.0B 16.8B

Cash Flow Trend

AbbVie Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 78.87
Forward P/E 15.15
Price to Book 228.56
Price to Sales 5.66
PEG Ratio 15.15

Profitability Ratios

Profit Margin 7.31%
Operating Margin 30.43%
Return on Equity 88.40%
Return on Assets 8.34%

Financial Health

Current Ratio 0.76
Debt to Equity 4,789.60
Beta 0.49

Per Share Data

EPS (TTM) $2.33
Book Value per Share $0.80
Revenue per Share $32.43

Peer Financial Comparison

Company Market Cap P/E Ratio P/B Ratio ROE Profit Margin Debt/Equity
abbv 324.6B 78.87 228.56 88.40% 7.31% 4,789.60
Eli Lilly and 691.8B 62.76 46.33 77.28% 22.67% 243.61
Johnson & Johnson 364.1B 16.83 4.66 29.45% 24.42% 66.90
Merck & Co 198.5B 11.49 4.12 39.29% 27.27% 71.99
Amgen 146.5B 24.84 23.60 105.67% 17.39% 924.46
Gilead Sciences 132.1B 22.31 6.90 32.65% 20.76% 130.79

Financial data is updated regularly. All figures are in the company's reporting currency.